Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01530477 · ClinicalTrials.gov registry record · NA

DXA Precision and Accuracy Comparison Study

A NA study, sponsored by GE Healthcare.

Terminated
Registry status
NA
Development phase
82
Enrollment target

NCT01530477 is a NA study that was terminated before completion, run by GE Healthcare. The registered enrollment target is 82 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01530477, a NA study, was terminated before completion, sponsored by GE Healthcare.

TERMINATED
Registry status
NA
Development phase
82 participants
Enrollment target

Study Summary

This study is being conducted to examine the performance of three common DXA machines (1) Lunar iDXA, (2) Lunar Prodigy and (3) Hologic Discovery A in measuring bone density and body fat.

Interventions

  • DEVICE Lunar Prodigy (GEHC)
  • DEVICE Lunar iDXA (GEHC)
  • DEVICE Discovery A (Hologic

Trial Details

FieldValue
Enrollment Target 82 participants
Start Date 2012-01
Est. Completion 2012-12
Phase NA

Sponsor

GE Healthcare

99 total trials

What the Registry Record Tells You About NCT01530477

The ClinicalTrials.gov registry entry for NCT01530477 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Lunar Prodigy (GEHC) is the first listed.

NCT01530477 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01530477 about?

NCT01530477 is a clinical study titled "DXA Precision and Accuracy Comparison Study". This study is being conducted to examine the performance of three common DXA machines (1) Lunar iDXA, (2) Lunar Prodigy and (3) Hologic Discovery A in measuring bone density and body fat.

What is the current status of trial NCT01530477?

This trial is currently terminated. It is a NA study. The enrollment target is 82 participants. The study started on 2012-01. Estimated completion is 2012-12.

What interventions are being tested in trial NCT01530477?

The interventions under investigation include: Lunar Prodigy (GEHC) (DEVICE), Lunar iDXA (GEHC) (DEVICE), Discovery A (Hologic (DEVICE).

Who is sponsoring clinical trial NCT01530477?

This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.